Collagen Solutions is one of the few listed companies headquartered in Scotland and has a global reach including staff in USA, Australia, New Zealand the UK and South Korea. The business is at an early stage and has a high growth trajectory going forward. The business engineers regenerative biomaterials and medical devices from natural collagen proteins, animal tissues and other biomaterials. Collagen Solutions apply their expertise across the value chain, from raw materials supply, product development, contract manufacturing, and their own proprietary products to address key markets and applications in regenerative medicine.
The business operates in a number of markets, their key markets are: orthopedics, dental, wounds and burns and cardiovascular.
The organisation has recently gone through a restructure with the consolidation of collagen manufacturing into the Glasgow centre of excellence which will contribute c£300k in increased operating profit of FY2019 as well as resulting in annualised cash savings of c£200k. The key figures for FY 2019 consisted of a group revenue number of £4,505,181 for the year ended 31 March 2019, up 10% on previous year, with a cash position of close to £6m. The business has been awarded a £1.5m research and development grant from Scottish Enterprise at the start of 2019. The grant will support around 39% of development costs for several of Collagen Solution’s early stage and upcoming proprietary product research and development programmes.
The Group Accountant will be a key member of the Collagen Solutions plc team in Glasgow and will report directly into the Global Group Financial Controller who in turn reports to the CFO. The role has been newly created due to continued and further projected growth.